RY 173.53 0.0461% SHOP 159.5 1.56% TD 76.22 0.8068% ENB 60.09 0.0333% BN 82.79 0.988% TRI 234.13 -0.1706% CNQ 43.47 0.6949% CP 105.63 0.4756% CNR 148.07 0.5637% BMO 139.11 -0.2152% BNS 77.03 -0.0649% CSU 4547.4502 0.8243% CM 92.53 0.2383% MFC 44.05 0.0454% ATD 80.59 0.1989% NGT 54.92 0.1459% TRP 66.54 0.2561% SU 50.61 0.4765% WCN 248.6 1.1885% L 191.07 -0.4325%

Leveljump Healthcare Corp

Healthcare CA JUMP

0.05CAD
-(-%)

Last update at 2024-12-24T14:30:00Z

Day Range

0.050.05
LowHigh

52 Week Range

0.050.10
LowHigh

Fundamentals

  • Previous Close 0.05
  • Market Cap4.82M
  • Volume0
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-0.49456M
  • Revenue TTM11.63M
  • Revenue Per Share TTM0.13
  • Gross Profit TTM 1.35M
  • Diluted EPS TTM-0.01

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-08-31 2021-08-31 2020-08-31 2019-08-31 2018-08-31
Type yearly yearly yearly yearly yearly
Date 2022-08-31 2021-08-31 2020-08-31 2019-08-31 2018-08-31
Income before tax 0.23M -2.22899M -0.12875M - -
Minority interest - - - - -
Net income 0.23M -2.22899M -0.12875M - -
Selling general administrative 3.06M 3.52M 0.13M - -
Selling and marketing expenses - - - - -
Gross profit 2.49M 1.35M 1.04M - -
Reconciled depreciation 0.21M 0.03M 0.03M - -
Ebit - -2.19686M -2.14975M 0.21M -0.02096M
Ebitda 0.59M -2.15758M -0.12875M - -
Depreciation and amortization - - - - -
Non operating income net other - - - - -
Operating income -0.77504M -2.19686M -0.12875M - -
Other operating expenses - - - - -
Interest expense 0.14M 0.04M 0.08M 0.00000M 0.00000M
Tax provision - - - - -
Interest income - - - - -
Net interest income -0.14314M -0.03782M -0.08121M - -
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense - - - - -
Total revenue 9.23M 6.72M 5.46M - -
Total operating expenses 10.00M 8.92M 0.13M - -
Cost of revenue 6.74M 5.37M 4.41M - -
Total other income expense net 1.15M 0.00569M -11.45324M - -
Discontinued operations - - - - -
Net income from continuing ops 0.23M -2.22899M -0.12875M - -
Net income applicable to common shares - -2.22899M -11.56304M 0.11M -0.10700M
Preferred stock and other adjustments - - - - -
Breakdown 2023-08-31 2022-08-31 2021-08-31 2020-08-31 2019-08-31
Type yearly yearly yearly yearly yearly
Date 2023-08-31 2022-08-31 2021-08-31 2020-08-31 2019-08-31
Total assets 19.54M 13.26M 4.10M 0.24M 0.14M
Intangible assets 6.09M 6.07M - - -
Earning assets - - - - -
Other current assets - - - - -
Total liab 14.60M 6.99M 2.12M 0.04M 0.03M
Total stockholder equity 4.94M 6.27M 1.98M 0.20M 0.11M
Deferred long term liab - - - - -
Other current liab - - - 0.34M 0.08M
Common stock - - 12.88M 10.98M 0.13M
Capital stock 16.22M 15.62M 12.88M 10.98M 0.15M
Retained earnings -16.68768M -14.40679M -14.64156M -12.41258M -0.84953M
Other liab - - 0.22M 0.12M -
Good will 3.73M - - - -
Other assets - - - - -
Cash 0.07M 0.08M 0.76M 0.91M -
Cash and equivalents - - - - -
Total current liabilities 4.27M 2.96M 1.90M 1.43M 1.36M
Current deferred revenue - - - - -
Net debt 7.67M 3.83M - - -
Short term debt - - - - -
Short long term debt 0.92M 0.51M - - -
Short long term debt total - - - - -
Other stockholder equity - - - - -
Property plant equipment - - 0.04M 0.05M 0.08M
Total current assets 2.33M 3.37M 3.95M 1.92M 0.62M
Long term investments 0.99M 2.52M 0.10M - -
Net tangible assets - - 1.98M 0.33M -0.71886M
Short term investments - - 1.33M - -
Net receivables 1.36M 1.36M 1.44M 0.65M 0.61M
Long term debt 6.82M 3.39M - 0.06M -
Inventory - - - - -
Accounts payable 2.53M 1.27M 1.87M 0.92M 1.04M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - - - - -
Deferred long term asset charges - - - - -
Non current assets total 17.21M 9.89M 0.15M 0.05M 0.00000M
Capital lease obligations 1.98M 0.27M 0.03M 0.06M -
Long term debt total - - - - -
Breakdown 2022-08-31 2021-08-31 2020-08-31 2019-08-31 2018-08-31
Type yearly yearly yearly yearly yearly
Date 2022-08-31 2021-08-31 2020-08-31 2019-08-31 2018-08-31
Investments -5.82484M -0.02547M 0.14M 0.14M 0.14M
Change to liabilities - -0.03980M -0.17304M 0.03M -0.20187M
Total cashflows from investing activities - -0.02547M 0.35M -0.00424M -0.01921M
Net borrowings - 0.06M 0.10M -0.01344M -0.09299M
Total cash from financing activities 5.46M 1.64M 3.54M -0.17271M 0.20M
Change to operating activities - -0.13042M -0.43768M 0.00137M -0.00408M
Net income 0.23M -2.22899M -11.56304M 0.11M -0.10700M
Change in cash -0.67330M -0.14929M 0.91M 0.07M -0.05475M
Begin period cash flow 0.76M 0.91M 0.12M - -
End period cash flow 0.08M 0.76M 0.22M 0.12M -
Total cash from operating activities -0.31118M -1.76598M -2.98513M 0.24M -0.23058M
Issuance of capital stock 2.52M 1.60M 0.23M - -
Depreciation 0.21M 0.03M 0.03M 0.06M 0.01M
Other cashflows from investing activities - - - - -
Dividends paid - - - - -
Change to inventory - - - - -
Change to account receivables -0.48016M -0.16589M -0.03248M -0.00693M 0.07M
Sale purchase of stock - - - - -
Other cashflows from financing activities - -0.04906M -0.00084M -0.15926M 0.29M
Change to netincome - 0.77M 9.19M 0.05M 0.00512M
Capital expenditures 1.65M 0.03M 0.00000M 0.00424M 0.02M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -0.02943M -0.33610M -0.00072M - -
Stock based compensation 0.29M 0.74M 0.04M - -
Other non cash items -1.02185M 0.01M 9.12M - -
Free cash flow -1.95849M -1.79145M -0.09183M - -

Peer Comparison

Sector: Healthcare Industry: Diagnostics & Research

Company Change (CAD) Price (CAD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
JUMP
Leveljump Healthcare Corp
- -% 0.05 - - 0.41 0.79 0.78 -7.3813
AVCR
Avricore Health Inc
- -% 0.06 - - 3.12 6.14 3.07 29.38
TELO
Telo Genomics Corp
- -% 0.12 - - - 16.43 -6.3236

Reports Covered

Stock Research & News

Profile

Leveljump Healthcare Corp., together with its subsidiaries, operates as a medical diagnostic imaging company. The company provides teleradiology services to its client hospitals. It also owns and operates imaging centers. Leveljump Healthcare Corp. is headquartered in Toronto, Canada.

Leveljump Healthcare Corp

52 Scarsdale Road, Toronto, ON, Canada, M3B 2R7

Key Executives

Name Title Year Born
Mr. Mitchell Geisler Pres, CEO & Chairman 1970
Mr. Robert Landau CFO, Corp. Sec. & Director 1971
Mr. Mitchell Geisler President, CEO & Chairman of the Board 1970
Mr. Robert G. Landau CFO, Corporate Secretary & Director 1971

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.